Iggy, if we get Amare, we'd probably trade Scola. I can't see having two upper-eschelon starting-quality PFs on the same team, especially not with Scola up for a contract extension or new contract after next season.
I've said before, I would rather have Scola than Stoudemire.
Or to put it another way: PFs, 2009-2010, 2010-2011
Stoudemire/Scola/Landry 09-10 - 23m; 10-11 - 28m; 11-12; 30m+ (dependent on Stoudemire extension)
Scola/Landry 09-10 - 6.75m; 10-11 - 12m; 11-12 - 14m
1st scenario, someone's getting traded
2nd scenario, we just lose the financial dollar-for-dollar production edge we've had on our best spot. If their production stays level, we're still only paying as much as we would be for a 2nd-tier A/S PF
PocketRockets wrote:Actually, Adelman was trying to get more players involved so we weren't dependent on any one player. Then people kept complaining why Yao wasn't getting the ball (even I said it at times), but it proved to be the right strategy by RA b/c look at how well we played at times when Yao went down. But two horses going down leaves for a really weak lineup and of course we'd lose to the champs.
I have a feeling Yao is going to have to have surgery again and will miss a lot of this next season. I hope it's not career ending, but it's a thought that runs in the back of my mind after i heard that it hasn't healed at all. =(

(except in reality, my nod is not smiling)
Morey 2020.
Q:How are they experts when they're always wrong?
A:Ask a stock market analyst or your financial advisor